Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,774 | Dovepress* | 9,640+ | 1,437 | 11,077 | |
PubMed Central* | 1,134 | 319 | 1,453 | ||
Totals | 10,774 | 1,756 | 12,530 | ||
*Since 22 July 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
9 | 0 | 0 | 0 | 1 | 8 |
View citations on PubMed Central and Google Scholar